Development of a biomarker panel to predict cardiac resynchronization therapy response: Results from the SMART-AV trial.

Development of a biomarker panel to predict cardiac resynchronization therapy response: Results from the SMART-AV trial. Heart Rhythm. 2019 05; 16(5):743-753.

View in: PubMed

subject areas

Aged
Biomarkers
Cardiac Resynchronization Therapy
C-Reactive Protein
Female
Heart Failure
Humans
Male
Matrix Metalloproteinase 2
Postoperative Period
Predictive Value of Tests
Prognosis
Receptors, Tumor Necrosis Factor, Type II

authors with profiles

John F. Beshai